![]() |
Name |
Alpha-Terpineol
|
Molecular Formula | C10H18O | |
IUPAC Name* |
2-(4-methylcyclohex-3-en-1-yl)propan-2-ol
|
|
SMILES |
CC1=CCC(CC1)C(C)(C)O
|
|
InChI |
InChI=1S/C10H18O/c1-8-4-6-9(7-5-8)10(2,3)11/h4,9,11H,5-7H2,1-3H3
|
|
InChIKey |
WUOACPNHFRMFPN-UHFFFAOYSA-N
|
|
Synonyms |
alpha-TERPINEOL; Terpineol; 98-55-5; 2-(4-methylcyclohex-3-en-1-yl)propan-2-ol; p-Menth-1-en-8-ol; 8000-41-7; dl-alpha-Terpineol; 1-p-Menthen-8-ol; .alpha.-Terpineol; Terpineol 350; 1-Menthene-8-ol; CARVOMENTHENOL; TERPINEOLS; FEMA No. 3045; 1-Methyl-4-isopropyl-1-cyclohexen-8-ol; alpha,alpha,4-Trimethyl-3-cyclohexene-1-methanol; 2-(4-Methyl-3-cyclohexenyl)-2-propanol; Terpineol schlechthin; Terpenol; alpha-Terpinenol; 1-Methyl-4-isopropyl-1-cyclohexene-8-ol; MFCD00001557; 8006-39-1; CHEBI:22469; 1-alpha-terpineol; 21334LVV8W; NSC-21449; NSC-403665; 3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-; NCGC00164431-01; NSC 21449; PC 593; DSSTox_CID_6625; DSSTox_RID_79596; DSSTox_GSID_40775; Terpilenol, alpha-; Terpene alcohol; FEMA Number 3045; alpha-Terpineol, analytical standard; alpha-Terpineol (natural); Menth-1-en-8-ol; 2-(4-methylcyclohex-3-enyl)propan-2-ol; CAS-8000-41-7; CCRIS 3204; 3-Cyclohexene-1-methanol,.alpha.4-trimethyl-; Caswell No. 823; HSDB 5316; EINECS 202-680-6; EINECS 219-448-5; 3-Cyclohexene-1-methanol, alpha,alpha,4-trimethyl-; BRN 1906604; UNII-R53Q4ZWC99; Alfa_terpineol; UNII-21334LVV8W; AI3-00275; Terpineol Normal; alpha -Terpineol; DL a-terpineol; Menthen-8-ol; EINECS 232-268-1; EPA Pesticide Chemical Code 067005; ALFA-TERPINEOL; 1-p-Menthen-8-; TERPINEOL OR; .ALPHA.TERPINEOL; TERPINEOL, ALPHA; d-1-p-Menthen-8-ol; (+)-.alpha.-Terpineol; 3-Cyclohexene-1-methanol, .alpha.,.alpha.4-trimethyl-; EC 202-680-6; EC 232-268-1; alpha-Terpineol, AldrichCPR; DSSTox_RID_78167; DSSTox_GSID_26625; SCHEMBL28466; ALPHA-TERPINEOL [FCC]; 3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-, (S)-; ALPHA-TERPINEOL [HSDB]; (1)-alpha,alpha,4-Trimethylcyclohex-3-ene-1-methanol; CHEMBL449810; R53Q4ZWC99; .ALPHA.-TERPINEOL [II]; .ALPHA.-TERPINEOL [MI]; ALFA-TERPINEOL [WHO-DD]; DTXSID5026625; MIL-350; .ALPHA.-TERPINEOL [FHFI]; HY-N5142; NSC21449; Tox21_112118; Tox21_200112; Tox21_302298; c0669; NSC403665; PC-593; 3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-, sodium salt, (1S)-; AKOS015840815; alpha-Terpineol, 90%, technical grade; SB45068; CAS-98-55-5; NCGC00248528-01; NCGC00255464-01; NCGC00257666-01; DB-059206; alpha-Terpineol 1000 microg/mL in n-Hexane; CS-0032554; FT-0622202; FT-0627680; FT-0698995; FT-0772029; T0022; T0984; 2-(4-methyl-1-cyclohex-3-enyl)-propan-2-ol; D70165; EN300-125883; (1R)-a,a,4-trimethyl-3-cyclohexene-1-methanol; SR-01000944873; J-500272; SR-01000944873-1; TERPIN MONOHYDRATE IMPURITY A [EP IMPURITY]; W-100076; Q27109437; F0001-2319; Z1255427148; alpha-Terpineol, primary pharmaceutical reference standard; 3-CYCLOHEXENE-1-METHANOL, ALPHA., .ALPHA., 4-TRIMETHYL-; 22347-88-2
|
|
CAS | 98-55-5 | |
PubChem CID | 17100 | |
ChEMBL ID | CHEMBL449810 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.25 | ALogp: | 1.8 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.575 |
Caco-2 Permeability: | -4.193 | MDCK Permeability: | 0.00001970 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.188 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.981 | Plasma Protein Binding (PPB): | 89.88% |
Volume Distribution (VD): | 1.307 | Fu: | 13.69% |
CYP1A2-inhibitor: | 0.112 | CYP1A2-substrate: | 0.301 |
CYP2C19-inhibitor: | 0.06 | CYP2C19-substrate: | 0.83 |
CYP2C9-inhibitor: | 0.059 | CYP2C9-substrate: | 0.87 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.311 |
CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.207 |
Clearance (CL): | 8.942 | Half-life (T1/2): | 0.527 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.087 |
Drug-inuced Liver Injury (DILI): | 0.034 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.012 | Maximum Recommended Daily Dose: | 0.09 |
Skin Sensitization: | 0.361 | Carcinogencity: | 0.71 |
Eye Corrosion: | 0.861 | Eye Irritation: | 0.982 |
Respiratory Toxicity: | 0.03 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001455 | ![]() |
0.532 | D07QKN | ![]() |
0.356 | ||
ENC000860 | ![]() |
0.471 | D0W8SB | ![]() |
0.189 | ||
ENC002325 | ![]() |
0.469 | D04CSZ | ![]() |
0.184 | ||
ENC001066 | ![]() |
0.436 | D0H1QY | ![]() |
0.184 | ||
ENC000555 | ![]() |
0.436 | D03SFU | ![]() |
0.181 | ||
ENC004620 | ![]() |
0.423 | D0O1UZ | ![]() |
0.179 | ||
ENC003371 | ![]() |
0.419 | D0P1FO | ![]() |
0.177 | ||
ENC002097 | ![]() |
0.412 | D09EBS | ![]() |
0.176 | ||
ENC001812 | ![]() |
0.404 | D00IUG | ![]() |
0.176 | ||
ENC002420 | ![]() |
0.385 | D0OK5I | ![]() |
0.175 |